{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:33:23Z","timestamp":1793734403581,"version":"4.6.1"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T00:00:00Z","timestamp":1235606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The HELLP syndrome is a serious complication in pregnancy characterized by haemolysis, elevated liver enzymes and low platelet count occurring in 0.5 to 0.9% of all pregnancies and in 10\u201320% of cases with severe preeclampsia. The present review highlights occurrence, diagnosis, complications, surveillance, corticosteroid treatment, mode of delivery and risk of recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical reports and reviews published between 2000 and 2008 were screened using Pub Med and Cochrane databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and conclusion<\/jats:title>\n                    <jats:p>\n                      About 70% of the cases develop before delivery, the majority between the 27th and 37th gestational weeks; the remainder within 48 hours after delivery. The HELLP syndrome may be complete or incomplete. In the Tennessee Classification System diagnostic criteria for HELLP are haemolysis with increased LDH (&gt; 600 U\/L), AST (\u2265 70 U\/L), and platelets &lt; 100\u00b710\n                      <jats:sup>9<\/jats:sup>\n                      \/L. The Mississippi Triple-class HELLP System further classifies the disorder by the nadir platelet counts. The syndrome is a progressive condition and serious complications are frequent. Conservative treatment (\u2265 48 hours) is controversial but may be considered in selected cases &lt; 34 weeks' gestation. Delivery is indicated if the HELLP syndrome occurs after the 34th gestational week or the foetal and\/or maternal conditions deteriorate. Vaginal delivery is preferable. If the cervix is unfavourable, it is reasonable to induce cervical ripening and then labour. In gestational ages between 24 and 34 weeks most authors prefer a single course of corticosteroid therapy for foetal lung maturation, either 2 doses of 12 mg betamethasone 24 hours apart or 6 mg or dexamethasone 12 hours apart before delivery. Standard corticosteroid treatment is, however, of uncertain clinical value in the maternal HELLP syndrome. High-dose treatment and repeated doses should be avoided for fear of long-term adverse effects on the foetal brain. Before 34 weeks' gestation, delivery should be performed if the maternal condition worsens or signs of intrauterine foetal distress occur. Blood pressure should be kept below 155\/105 mmHg. Close surveillance of the mother should be continued for at least 48 hours after delivery.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1471-2393-9-8","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T14:14:24Z","timestamp":1235657664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":474,"title":["The HELLP syndrome: Clinical issues and management. A Review"],"prefix":"10.1186","volume":"9","author":[{"given":"Kjell","family":"Haram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Abildgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,26]]},"reference":[{"key":"206_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM195401212500301","volume":"250","author":"JA Pritchard","year":"1954","unstructured":"Pritchard JA, Weisman R, Ratnoff OD, Vosburgh GJ: Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med. 1954, 250: 89-98.","journal-title":"N Engl J Med"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ajog.2005.02.113","volume":"193","author":"L Weinstein","year":"2005","unstructured":"Weinstein L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. 1982. Am J Obstet Gynecol. 2005, 193: 859-10.1016\/j.ajog.2005.02.113.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0002-9378(96)70162-X","volume":"175","author":"F Audibert","year":"1996","unstructured":"Audibert F, Friedman SA, Frangieh AY, Sibai BM: Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1996, 175: 460-464. 10.1016\/S0002-9378(96)70162-X.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1081\/JDI-120022553","volume":"25","author":"C Celik","year":"2003","unstructured":"Celik C, Gezginc K, Altintepe L, Tonbul HZ, Yaman ST, Akyurek C, Turk S: Results of the pregnancies with HELLP syndrome. Ren Fail. 2003, 25: 613-618. 10.1081\/JDI-120022553.","journal-title":"Ren Fail"},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1515\/JPM.2002.076","volume":"30","author":"AK Ertan","year":"2002","unstructured":"Ertan AK, Wagner S, Hendrik HJ, Tanriverdi HA, Schmidt W: Clinical and biophysical aspects of HELLP-syndrome. J Perinat Med. 2002, 30: 483-489. 10.1515\/JPM.2002.076.","journal-title":"J Perinat Med"},{"key":"206_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/00003081-199909000-00009","volume":"42","author":"EF Magann","year":"1999","unstructured":"Magann EF, Martin JN: Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol. 1999, 42: 532-550. 10.1097\/00003081-199909000-00009.","journal-title":"Clin Obstet Gynecol"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ajog.2005.08.044","volume":"195","author":"JN Martin Jr","year":"2006","unstructured":"Martin JN, Rose CH, Briery CM: Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006, 195: 914-934. 10.1016\/j.ajog.2005.08.044.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai BM: The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am J Obstet Gynecol. 1990, 162: 311-316.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","volume":"103","author":"BM Sibai","year":"2004","unstructured":"Sibai BM: Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004, 103: 981-991.","journal-title":"Obstet Gynecol"},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.clp.2004.06.008","volume":"31","author":"JR Barton","year":"2004","unstructured":"Barton JR, Sibai BM: Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004, 31: 807-33. 10.1016\/j.clp.2004.06.008.","journal-title":"Clin Perinatol"},{"key":"206_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.12968\/hosp.1999.60.4.1089","volume":"60","author":"J Ellison","year":"1999","unstructured":"Ellison J, Sattar N, Greer I: HELLP syndrome: mechanisms and management. Hosp Med. 1999, 60: 243-249.","journal-title":"Hosp Med"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2169\/internalmedicine.42.1052","volume":"42","author":"M Matsuda","year":"2003","unstructured":"Matsuda M, Mitsuhashi S, Watarai M, Yamamoto K, Hashimoto T, Ikeda S: Hemolysis, elevated liver enzymes and low platelet (HELLP) syndrome associated with systemic lupus erythematosus. Intern Med. 2003, 42: 1052-1053. 10.2169\/internalmedicine.42.1052.","journal-title":"Intern Med"},{"key":"206_CR13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.WNO.0000165102.93612.57","volume":"25","author":"MA Murphy","year":"2005","unstructured":"Murphy MA, Ayazifar M: Permanent visual deficits secondary to the HELLP syndrome. J Neuroophthalmol. 2005, 25: 122-127.","journal-title":"J Neuroophthalmol"},{"key":"206_CR14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","volume":"169","author":"BM Sibai","year":"1993","unstructured":"Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA: Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993, 169: 1000-1006.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1471-0528.1997.tb14346.x","volume":"104","author":"M Geary","year":"1997","unstructured":"Geary M: The HELLP syndrome. Br J Obstet Gynaecol. 1997, 104: 887-891.","journal-title":"Br J Obstet Gynaecol"},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1111\/j.1523-1755.2005.00316.x","volume":"67","author":"SA Karumanchi","year":"2005","unstructured":"Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP: Preeclampsia: a renal perspective. Kidney Int. 2005, 67: 2101-2113. 10.1111\/j.1523-1755.2005.00316.x.","journal-title":"Kidney Int"},{"key":"206_CR17","first-page":"829","volume":"60","author":"MO Padden","year":"1999","unstructured":"Padden MO: HELLP syndrome: recognition and perinatal management. Am Fam Physician. 1999, 60: 829-838.","journal-title":"Am Fam Physician"},{"key":"206_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-0528.1986.tb07879.x","volume":"93","author":"JG Aarnoudse","year":"1986","unstructured":"Aarnoudse JG, Houthoff HJ, Weits J, Vellenga E, Huisjes HJ: A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy. A clinical and histopathological study. Br J Obstet Gynaecol. 1986, 93: 145-155.","journal-title":"Br J Obstet Gynaecol"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/14767050500380976","volume":"19","author":"SV Koenen","year":"2006","unstructured":"Koenen SV, Huisjes AJ, Dings J, van der GY, Visser GH, Bruinse HW: Is there a diurnal pattern in the clinical symptoms of HELLP syndrome?. J Matern Fetal Neonatal Med. 2006, 19: 93-99. 10.1080\/14767050500380976.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"206_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1471-0528.1995.tb09062.x","volume":"102","author":"W Visser","year":"1995","unstructured":"Visser W, Wallenburg HC: Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol. 1995, 102: 111-117.","journal-title":"Br J Obstet Gynaecol"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/01.ogx.0000146948.19308.c5","volume":"59","author":"JK Baxter","year":"2004","unstructured":"Baxter JK, Weinstein L: HELLP syndrome: the state of the art. Obstet Gynecol Surv. 2004, 59: 838-845. 10.1097\/01.ogx.0000146948.19308.c5.","journal-title":"Obstet Gynecol Surv"},{"key":"206_CR22","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1001\/jama.243.19.1909","volume":"243","author":"A Marchand","year":"1980","unstructured":"Marchand A, Galen RS, Van LF: The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980, 243: 1909-1911. 10.1001\/jama.243.19.1909.","journal-title":"JAMA"},{"key":"206_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0020-7292(92)90776-F","volume":"39","author":"G Wilke","year":"1992","unstructured":"Wilke G, Rath W, Schutz E, Armstrong VW, Kuhn W: Haptoglobin as a sensitive marker of hemolysis in HELLP-syndrome. Int J Gynaecol Obstet. 1992, 39: 29-34. 10.1016\/0020-7292(92)90776-F.","journal-title":"Int J Gynaecol Obstet"},{"key":"206_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1515\/JPM.2000.033","volume":"28","author":"W Rath","year":"2000","unstructured":"Rath W, Faridi A, Dudenhausen JW: HELLP syndrome. J Perinat Med. 2000, 28: 249-260. 10.1515\/JPM.2000.033.","journal-title":"J Perinat Med"},{"key":"206_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejogrb.2005.07.011","volume":"125","author":"P Deruelle","year":"2006","unstructured":"Deruelle P, Coudoux E, Ego A, Houfflin-Debarge V, Codaccioni X, Subtil D: Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. Eur J Obstet Gynecol Reprod Biol. 2006, 125: 59-65. 10.1016\/j.ejogrb.2005.07.011.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"206_CR26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0002-9378(87)80308-3","volume":"157","author":"PA Poldre","year":"1987","unstructured":"Poldre PA: Haptoglobin helps diagnose the HELLP syndrome. Am J Obstet Gynecol. 1987, 157: 1267-","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/01.ogx.0000150346.42901.07","volume":"60","author":"PJ van Runnard Heimel","year":"2005","unstructured":"van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW: Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv. 2005, 60: 57-70. 10.1097\/01.ogx.0000150346.42901.07.","journal-title":"Obstet Gynecol Surv"},{"key":"206_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0002-9378(98)70645-3","volume":"178","author":"MF Knapen","year":"1998","unstructured":"Knapen MF, Mulder TP, Bisseling JG, Penders RH, Peters WH, Steegers EA: Plasma glutathione S-transferase alpha 1-1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1998, 178: 161-165. 10.1016\/S0002-9378(98)70645-3.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2005.12.031","volume":"128","author":"M Parnas","year":"2006","unstructured":"Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, Holcberg G, Yerushalmi R: Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2006, 128: 163-168. 10.1016\/j.ejogrb.2005.12.031.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"206_CR30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/bmj.1.6111.467","volume":"1","author":"CW Redman","year":"1978","unstructured":"Redman CW, Bonnar J, Beilin L: Early platelet consumption in pre-eclampsia. Br Med J. 1978, 1: 467-469.","journal-title":"Br Med J"},{"key":"206_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9378(86)90803-3","volume":"155","author":"TM Stubbs","year":"1986","unstructured":"Stubbs TM, Lazarchick J, Van Dorsten JP, Cox J, Loadholt CB: Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol. 1986, 155: 263-265.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.clp.2004.06.007","volume":"31","author":"BM Sibai","year":"2004","unstructured":"Sibai BM: Imitators of severe pre-eclampsia\/eclampsia. Clin Perinatol. 2004, 31: 835-852. 10.1016\/j.clp.2004.06.007.","journal-title":"Clin Perinatol"},{"key":"206_CR33","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/0002-9378(91)91429-Z","volume":"164","author":"JN Martin Jr","year":"1991","unstructured":"Martin JN, Blake PG, Perry KG, McCaul JF, Hess LW, Martin RW: The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol. 1991, 164: 1500-1509.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR34","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0002-9378(99)70022-0","volume":"180","author":"JN Martin Jr","year":"1999","unstructured":"Martin JN, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG: The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999, 180: 1373-1384. 10.1016\/S0002-9378(99)70022-0.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1067\/mob.2000.105915","volume":"183","author":"B Haddad","year":"2000","unstructured":"Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM: Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000, 183: 444-448. 10.1067\/mob.2000.105915.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1590\/S1516-31802006000200007","volume":"124","author":"MA Osmanagaoglu","year":"2006","unstructured":"Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H: Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital. Sao Paulo Med J. 2006, 124: 85-89. 10.1590\/S1516-31802006000200007.","journal-title":"Sao Paulo Med J"},{"key":"206_CR37","first-page":"2253","volume":"126","author":"R Svenningsen","year":"2006","unstructured":"Svenningsen R, Morken NH, Kahn JA: Corticosteroids in the treatment of HELLP-syndrome?. Tidsskr Nor Laegeforen. 2006, 126: 2253-2256.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"206_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s005950200074","volume":"32","author":"M Aldemir","year":"2002","unstructured":"Aldemir M, Bac B, Tacyildiz I, Yagmur Y, Keles C: Spontaneous liver hematoma and a hepatic rupture in HELLP syndrome: report of two cases. Surg Today. 2002, 32: 450-453. 10.1007\/s005950200074.","journal-title":"Surg Today"},{"key":"206_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/biof.5520250118","volume":"25","author":"SR Giannubilo","year":"2005","unstructured":"Giannubilo SR, Tranquilli AL, Santolini C, Prinicipi F, Mancinelli R, Littarru GP: Placental CoQ10 levels in HELLP syndrome. Biofactors. 2005, 25: 159-163. 10.1002\/biof.5520250118.","journal-title":"Biofactors"},{"key":"206_CR40","first-page":"19","volume":"79","author":"M Haeger","year":"1992","unstructured":"Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A: Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 1992, 79: 19-26.","journal-title":"Obstet Gynecol"},{"key":"206_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/14767050400018015","volume":"16","author":"JC Smulian","year":"2004","unstructured":"Smulian JC, Shen-Schwarz S, Scorza WE, Kinzler WL, Vintzileos AM: A clinicohistopathological comparison between HELLP syndrome and severe preeclampsia. Journal of Maternal-Fetal and Neonatal Medicine. 2004, 16: 287-293. 10.1080\/14767050400018015.","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"206_CR42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.0001-6349.2005.00756.x","volume":"84","author":"AL Tranquilli","year":"2005","unstructured":"Tranquilli AL, Giannubilo SR, Tedeschi E, Bezzeccheri V, Suzuki H, Menegazzi M: Placental expression of nitric oxide synthase during HELLP syndrome: the correlation with maternal-fetal Doppler velocimetry. Acta Obstet Gynecol Scand. 2005, 84: 849-853. 10.1111\/j.0001-6349.2005.00756.x.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"206_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/01443610600810989","volume":"26","author":"S Chhabra","year":"2006","unstructured":"Chhabra S, Qureshi A, Datta N: Perinatal outcome with HELLP\/partial HELLP complicating hypertensive disorders of pregnancy. An Indian rural experience. J Obstet Gynaecol. 2006, 26: 531-533. 10.1080\/01443610600810989.","journal-title":"J Obstet Gynaecol"},{"key":"206_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1515\/JPM.2003.027","volume":"31","author":"AC Roelofsen","year":"2003","unstructured":"Roelofsen AC, van Pampus MG, Aarnoudse JG: The HELLP-syndrome; maternal-fetal outcome and follow up of infants. J Perinat Med. 2003, 31: 201-208. 10.1515\/JPM.2003.027.","journal-title":"J Perinat Med"},{"key":"206_CR45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9378(86)90266-8","volume":"155","author":"BM Sibai","year":"1986","unstructured":"Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986, 155: 501-509.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0002-9378(76)90841-3","volume":"125","author":"RC Goodlin","year":"1976","unstructured":"Goodlin RC: Severe pre-eclampsia: another great imitator. Am J Obstet Gynecol. 1976, 125: 747-753.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR47","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJM199906033402204","volume":"340","author":"JA Ibdah","year":"1999","unstructured":"Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW: A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999, 340: 1723-1731. 10.1056\/NEJM199906033402204.","journal-title":"N Engl J Med"},{"key":"206_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJM199608223350807","volume":"335","author":"TA Knox","year":"1996","unstructured":"Knox TA, Olans LB: Liver disease in pregnancy. N Engl J Med. 1996, 335: 569-576. 10.1056\/NEJM199608223350807.","journal-title":"N Engl J Med"},{"key":"206_CR49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MOH.0b013e3280dce531","volume":"14","author":"E Groot","year":"2007","unstructured":"Groot E, de Groot PG, Fijnheer R, Lenting PJ: The presence of active von Willebrand factor under various pathological conditions. Curr Opin Hematol. 2007, 14: 284-289. 10.1097\/MOH.0b013e3280dce531.","journal-title":"Curr Opin Hematol"},{"key":"206_CR50","first-page":"2250","volume":"123","author":"K Haram","year":"2003","unstructured":"Haram K, Softeland E, Hervig T, Pirhonen J: Thrombocytopaenia in pregnancy. Tidsskr Nor Laegeforen. 2003, 123: 2250-2252.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"206_CR51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/OGX.0b013e318164013c","volume":"63","author":"R Sukenik-Halevy","year":"2008","unstructured":"Sukenik-Halevy R, Ellis MH, Fejgin MD: Management of immune thrombocytopenic purpura in pregnancy. Obstet Gynecol Surv. 2008, 63: 182-188. 10.1097\/OGX.0b013e318164013c.","journal-title":"Obstet Gynecol Surv"},{"key":"206_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10245330600667583","volume":"11","author":"M Franchini","year":"2006","unstructured":"Franchini M: Thrombotic microangiopathies: an update. Hematology. 2006, 11: 139-146. 10.1080\/10245330600667583.","journal-title":"Hematology"},{"key":"206_CR53","first-page":"166","volume":"72","author":"SA Mayer","year":"2005","unstructured":"Mayer SA, Aledort LM: Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. Mt Sinai J Med. 2005, 72: 166-175.","journal-title":"Mt Sinai J Med"},{"key":"206_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/ard.2003.019000","volume":"64","author":"TD Le Thi","year":"2005","unstructured":"Le Thi TD, Tieulie N, Costedoat N, Andreu MR, Wechsler B, Vauthier-Brouzes D, Aumaitre O, Piette JC: The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis. 2005, 64: 273-278. 10.1136\/ard.2003.019000.","journal-title":"Ann Rheum Dis"},{"key":"206_CR55","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0029-7844(97)00209-3","volume":"90","author":"SP Walker","year":"1997","unstructured":"Walker SP, Wein P, Ihle BU: Severe folate deficiency masquerading as the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol. 1997, 90: 655-657. 10.1016\/S0029-7844(97)00209-3.","journal-title":"Obstet Gynecol"},{"key":"206_CR56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.jp.7200165","volume":"19","author":"WM Curtin","year":"1999","unstructured":"Curtin WM, Weinstein L: A reviuw of HELLP syndrome. Journal of Perinatology. 1999, 19: 138-143. 10.1038\/sj.jp.7200165.","journal-title":"Journal of Perinatology"},{"key":"206_CR57","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/00016340601185384","volume":"86","author":"S Cavkaytar","year":"2007","unstructured":"Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N: Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome?. Acta Obstet Gynecol Scand. 2007, 86: 648-651. 10.1080\/00016340601185384.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"206_CR58","first-page":"97","volume":"73","author":"PA Van Dam","year":"1989","unstructured":"Van Dam PA, Renier M, Baekelandt M, Buytaert P, Uyttenbroeck F: Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Obstet Gynecol. 1989, 73: 97-102.","journal-title":"Obstet Gynecol"},{"key":"206_CR59","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/0002-9378(93)90678-C","volume":"168","author":"BM Sibai","year":"1993","unstructured":"Sibai BM, Ramadan MK: Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol. 1993, 168: 1682-1687.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1081\/JDI-200031750","volume":"26","author":"A Gul","year":"2004","unstructured":"Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y: Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Ren Fail. 2004, 26: 557-562. 10.1081\/JDI-200031750.","journal-title":"Ren Fail"},{"key":"206_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajog.2006.01.016","volume":"195","author":"AC Araujo","year":"2006","unstructured":"Araujo AC, Leao MD, Nobrega MH, Bezerra PF, Pereira FV, Dantas EM, Azevedo GD, Jeronimo SM: Characteristics and treatment of hepatic rupture caused by HELLP syndrome. Am J Obstet Gynecol. 2006, 195: 129-133. 10.1016\/j.ajog.2006.01.016.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR62","first-page":"244","volume":"26","author":"CJ Das","year":"2007","unstructured":"Das CJ, Srivastava DN, Debnath J, Ramchandran V, Pal S, Sahni P: Endovascular management of hepatic hemorrhage and subcapsular hematoma in HELLP syndrome. Indian J Gastroenterol. 2007, 26: 244-245.","journal-title":"Indian J Gastroenterol"},{"key":"206_CR63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajog.2003.08.029","volume":"190","author":"C Wicke","year":"2004","unstructured":"Wicke C, Pereira PL, Neeser E, Flesch I, Rodegerdts EA, Becker HD: Subcapsular liver hematoma in HELLP syndrome: Evaluation of diagnostic and therapeutic options \u2013 a unicenter study. Am J Obstet Gynecol. 2004, 190: 106-112. 10.1016\/j.ajog.2003.08.029.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR64","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/01.AOG.0000127943.68645.96","volume":"103","author":"SH Merchant","year":"2004","unstructured":"Merchant SH, Mathew P, Vanderjagt TJ, Howdieshell TR, Crookston KP: Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol. 2004, 103: 1055-1058.","journal-title":"Obstet Gynecol"},{"key":"206_CR65","first-page":"224","volume":"74","author":"AR Pliego Perez","year":"2006","unstructured":"Pliego Perez AR, Zavala Soto JO, Rodriguez BR, Martinez Herrera FJ, Porras JA: Spontaneous hepatic rupture of pregnancy. A report of four cases and medical literature review. Ginecol Obstet Mex. 2006, 74: 224-231.","journal-title":"Ginecol Obstet Mex"},{"key":"206_CR66","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1046\/j.1538-7836.2003.00253.x","volume":"1","author":"R Pauzner","year":"2003","unstructured":"Pauzner R, Dulitzky M, Carp H, Mayan H, Kenett R, Farfel Z, Many A: Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. J Thromb Haemost. 2003, 1: 1758-1763. 10.1046\/j.1538-7836.2003.00253.x.","journal-title":"J Thromb Haemost"},{"key":"206_CR67","first-page":"890","volume":"25","author":"RA Asherson","year":"2007","unstructured":"Asherson RA, Schamroth-Rapaport N, Skudowitz B, Singh S, Marx D, Miesbach W: Recurrent deep vein thrombosis, ovarian carcinoma and antibodies to mitochondria M5 in a patient with asymptomatic primary \"plus\" antiphospholipid syndrome: an unusual combination. Clin Exp Rheumatol. 2007, 25: 890-895.","journal-title":"Clin Exp Rheumatol"},{"key":"206_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10072-005-0380-2","volume":"26","author":"C Altamura","year":"2005","unstructured":"Altamura C, Vasapollo B, Tibuzzi F, Novelli GP, Valensise H, Rossini PM, Vernieri F: Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome. Neurol Sci. 2005, 26: 40-42. 10.1007\/s10072-005-0380-2.","journal-title":"Neurol Sci"},{"key":"206_CR69","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000064564","volume":"53","author":"Y Soh","year":"2002","unstructured":"Soh Y, Yasuhi I, Nakayama D, Ishimaru T: A case of postpartum cerebellar infarction with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome. Gynecol Obstet Invest. 2002, 53: 240-242. 10.1159\/000064564.","journal-title":"Gynecol Obstet Invest"},{"key":"206_CR70","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/archneur.62.7.1150","volume":"62","author":"LA Zeidman","year":"2005","unstructured":"Zeidman LA, Videnovic A, Bernstein LP, Pellar CA: Lethal pontine hemorrhage in postpartum syndrome of hemolysis, elevated liver enzyme levels, and low platelet count. Arch Neurol. 2005, 62: 1150-1153. 10.1001\/archneur.62.7.1150.","journal-title":"Arch Neurol"},{"key":"206_CR71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2176\/nmc.41.144","volume":"41","author":"K Hashiguchi","year":"2001","unstructured":"Hashiguchi K, Inamura T, Irita K, Abe M, Noda E, Yanai S, Takahashi S, Fukui M: Late occurrence of diffuse cerebral swelling after intracerebral hemorrhage in a patient with the HELLP syndrome \u2013 Case report. Neurol Med Chir (Tokyo). 2001, 41: 144-148. 10.2176\/nmc.41.144.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"206_CR72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000082648","volume":"59","author":"A Gul","year":"2005","unstructured":"Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y: Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest. 2005, 59: 113-118. 10.1159\/000082648.","journal-title":"Gynecol Obstet Invest"},{"key":"206_CR73","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1515\/JPM.2004.132","volume":"32","author":"MA Osmanagaoglu","year":"2004","unstructured":"Osmanagaoglu MA, Erdogan I, Zengin U, Bozkaya H: Comparison between HELLP syndrome, chronic hypertension, and superimposed preeclampsia on chronic hypertension without HELLP syndrome. J Perinat Med. 2004, 32: 481-485. 10.1515\/JPM.2004.132.","journal-title":"J Perinat Med"},{"key":"206_CR74","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000078679","volume":"58","author":"H Aslan","year":"2004","unstructured":"Aslan H, Gul A, Cebeci A: Neonatal outcome in pregnancies after preterm delivery for HELLP syndrome. Gynecol Obstet Invest. 2004, 58: 96-99. 10.1159\/000078679.","journal-title":"Gynecol Obstet Invest"},{"key":"206_CR75","first-page":"266","volume":"17","author":"DS Raval","year":"1997","unstructured":"Raval DS, Co S, Reid MA, Pildes R: Maternal and neonatal outcome of pregnancies complicated with maternal HELLP syndrome. J Perinatol. 1997, 17: 266-269.","journal-title":"J Perinatol"},{"key":"206_CR76","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3349\/ymj.2006.47.3.393","volume":"47","author":"HY Kim","year":"2006","unstructured":"Kim HY, Sohn YS, Lim JH, Kim EH, Kwon JY, Park YW, Kim YH: Neonatal outcome after preterm delivery in HELLP syndrome. Yonsei Med J. 2006, 47: 393-398.","journal-title":"Yonsei Med J"},{"key":"206_CR77","first-page":"16","volume":"94","author":"D Murray","year":"2001","unstructured":"Murray D, O'Riordan M, Geary M, Phillips R, Clarke T, McKenna P: The HELLP syndrome: maternal and perinatal outcome. Ir Med J. 2001, 94: 16-18.","journal-title":"Ir Med J"},{"key":"206_CR78","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/00006254-199903000-00024","volume":"54","author":"BK Rinehart","year":"1999","unstructured":"Rinehart BK, Terrone DA, Magann EF, Martin RW, May WL, Martin JN: Preeclampsia-associated hepatic hemorrhage and rupture: mode of management related to maternal and perinatal outcome. Obstet Gynecol Surv. 1999, 54: 196-202. 10.1097\/00006254-199903000-00024.","journal-title":"Obstet Gynecol Surv"},{"key":"206_CR79","first-page":"219","volume":"8","author":"Y Gilboa","year":"2006","unstructured":"Gilboa Y, Bardin R, Feldberg D, Bachar GN: Postpartum hepatic rupture and retroperitoneal hematoma associated with HELLP syndrome. Isr Med Assoc J. 2006, 8: 219-220.","journal-title":"Isr Med Assoc J"},{"key":"206_CR80","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ajo.2006.12.005","volume":"143","author":"MW Stewart","year":"2007","unstructured":"Stewart MW, Brazis PW, Guier CP, Thota SH, Wilson SD: Purtscher-like retinopathy in a patient with HELLP syndrome. Am J Ophthalmol. 2007, 143: 886-887. 10.1016\/j.ajo.2006.12.005.","journal-title":"Am J Ophthalmol"},{"key":"206_CR81","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJM199609123351102","volume":"335","author":"SJ Kittner","year":"1996","unstructured":"Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, et al: Pregnancy and the risk of stroke. N Engl J Med. 1996, 335: 768-774. 10.1056\/NEJM199609123351102.","journal-title":"N Engl J Med"},{"key":"206_CR82","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.jp.7200165","volume":"19","author":"WM Curtin","year":"1999","unstructured":"Curtin WM, Weinstein L: A review of HELLP syndrome. Journal of Perinatology. 1999, 19: 138-143. 10.1038\/sj.jp.7200165.","journal-title":"Journal of Perinatology"},{"key":"206_CR83","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0889-8588(05)70169-6","volume":"14","author":"RL Bick","year":"2000","unstructured":"Bick RL: Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and management. Hematol Oncol Clin North Am. 2000, 14: 999-1044. 10.1016\/S0889-8588(05)70169-6.","journal-title":"Hematol Oncol Clin North Am"},{"key":"206_CR84","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.jp.7211265","volume":"25","author":"L Detti","year":"2005","unstructured":"Detti L, Mecacci F, Piccioli A, Ferrarello S, Carignani L, Mello G, Ferguson JE, Scarselli G: Postpartum heparin therapy for patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) is associated with significant hemorrhagic complications. J Perinatol. 2005, 25: 236-240. 10.1038\/sj.jp.7211265.","journal-title":"J Perinatol"},{"key":"206_CR85","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0020-7292(95)02463-M","volume":"50","author":"DM Paternoster","year":"1995","unstructured":"Paternoster DM, Stella A, Simioni P, Mussap M, Plebani M: Coagulation and plasma fibronectin parameters in HELLP syndrome. Int J Gynaecol Obstet. 1995, 50: 263-268. 10.1016\/0020-7292(95)02463-M.","journal-title":"Int J Gynaecol Obstet"},{"key":"206_CR86","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1067\/mob.2002.120279","volume":"186","author":"AJ Drakeley","year":"2002","unstructured":"Drakeley AJ, Le Roux PA, Anthony J, Penny J: Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol. 2002, 186: 253-256. 10.1067\/mob.2002.120279.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR87","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1067\/S0002-9378(03)00763-4","volume":"189","author":"JN Martin Jr","year":"2003","unstructured":"Martin JN, Thigpen BD, Rose CH, Cushman J, Moore A, May WL: Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol. 2003, 189: 830-834. 10.1067\/S0002-9378(03)00763-4.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR88","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00404-005-0741-3","volume":"273","author":"Y\u00fccesoy","year":"2005","unstructured":"Y\u00fccesoy , Ozkan S, Bodur H, Tan T, Caliskan E, Vural B, Corakci A: Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet. 2005, 273: 43-49. 10.1007\/s00404-005-0741-3.","journal-title":"Arch Gynecol Obstet"},{"key":"206_CR89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00414-004-0484-x","volume":"119","author":"M Simic","year":"2005","unstructured":"Simic M, Tasic M, Stojiljkovic G, Draskovic D, Vukovic R: HELLP syndrome as a cause of unexpected rapid maternal death \u2013 a case report and review of the literature. Int J Legal Med. 2005, 119: 103-106. 10.1007\/s00414-004-0484-x.","journal-title":"Int J Legal Med"},{"key":"206_CR90","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0002-9378(99)70343-1","volume":"181","author":"CM Isler","year":"1999","unstructured":"Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN: Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1999, 181: 924-928. 10.1016\/S0002-9378(99)70343-1.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR91","first-page":"419","volume":"16","author":"D Mihu","year":"2007","unstructured":"Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R: HELLP syndrome \u2013 a multisystemic disorder. J Gastrointestin Liver Dis. 2007, 16: 419-424.","journal-title":"J Gastrointestin Liver Dis"},{"key":"206_CR92","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0002-9378(99)70178-X","volume":"180","author":"D Abramovici","year":"1999","unstructured":"Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM: Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?. Am J Obstet Gynecol. 1999, 180: 221-225. 10.1016\/S0002-9378(99)70178-X.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-994387","volume":"12","author":"K Harms","year":"1995","unstructured":"Harms K, Rath W, Herting E, Kuhn W: Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome. Am J Perinatol. 1995, 12: 1-6. 10.1055\/s-2007-994387.","journal-title":"Am J Perinatol"},{"key":"206_CR94","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1440-1754.2004.00311.x","volume":"40","author":"N Singhal","year":"2004","unstructured":"Singhal N, Amin HJ, Pollard JK, Tough SC, Johnston DW, Clark DJ, Sauve R: Maternal haemolysis, elevated liver enzymes and low platelets syndrome: perinatal and neurodevelopmental neonatal outcomes for infants weighing less than 1250 g. J Paediatr Child Health. 2004, 40: 121-126. 10.1111\/j.1440-1754.2004.00311.x.","journal-title":"J Paediatr Child Health"},{"key":"206_CR95","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s004310050621","volume":"156","author":"J D\u00f6tsch","year":"1997","unstructured":"D\u00f6tsch J, Hohmann M, Kuhl PG: Neonatal morbidity and mortality associated with maternal haemolysis elevated liver enzymes and low platelets syndrome. Eur J Pediatr. 1997, 156: 389-391. 10.1007\/s004310050621.","journal-title":"Eur J Pediatr"},{"key":"206_CR96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/jpme.1992.20.1.25","volume":"20","author":"L Gortner","year":"1992","unstructured":"Gortner L, Pohlandt F, Bartmann P, Terinde R, Versmold H, Dorigo O: Short-term outcome in infants with birth weights less than 1750 g born to mothers with HELLP syndrome. J Perinat Med. 1992, 20: 25-28.","journal-title":"J Perinat Med"},{"key":"206_CR97","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1515\/jpme.1998.26.6.486","volume":"26","author":"C Kandler","year":"1998","unstructured":"Kandler C, Kevekordes B, Zenker M, Kandler M, Beinder E, Lang N, Harms D: Prognosis of children born to mothers with HELLP-syndrome. J Perinat Med. 1998, 26: 486-490.","journal-title":"J Perinat Med"},{"key":"206_CR98","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","volume":"171","author":"BM Sibai","year":"1994","unstructured":"Sibai BM, Mercer BM, Schiff E, Friedman SA: Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994, 171: 818-822.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR99","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/01.grf.0000160315.67359.e6","volume":"48","author":"B Haddad","year":"2005","unstructured":"Haddad B, Sibai BM: Expectant management of severe preeclampsia: proper candidates and pregnancy outcome. Clin Obstet Gynecol. 2005, 48: 430-440. 10.1097\/01.grf.0000160315.67359.e6.","journal-title":"Clin Obstet Gynecol"},{"key":"206_CR100","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/siny.2000.0023","volume":"5","author":"F Paruk","year":"2000","unstructured":"Paruk F, Moodley J: Maternal and neonatal outcome in early- and late-onset pre-eclampsia. Semin Neonatol. 2000, 5: 197-207. 10.1053\/siny.2000.0023.","journal-title":"Semin Neonatol"},{"key":"206_CR101","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.grf.0000160309.73197.35","volume":"48","author":"JM O'Brien","year":"2005","unstructured":"O'Brien JM, Barton JR: Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol. 2005, 48: 460-477. 10.1097\/01.grf.0000160309.73197.35.","journal-title":"Clin Obstet Gynecol"},{"key":"206_CR102","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0301-2115(97)00146-2","volume":"76","author":"MG van Pampus","year":"1998","unstructured":"van Pampus MG, Wolf H, Westenberg SM, Post van der JA, Bonsel GJ, Treffers PE: Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 1998, 76: 31-36. 10.1016\/S0301-2115(97)00146-2.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"206_CR103","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMe078161","volume":"357","author":"AD Stiles","year":"2007","unstructured":"Stiles AD: Prenatal corticosteroids \u2013 early gain, long-term questions. N Engl J Med. 2007, 357: 1248-1250. 10.1056\/NEJMe078161.","journal-title":"N Engl J Med"},{"key":"206_CR104","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ajog.2004.01.044","volume":"190","author":"AH Jobe","year":"2004","unstructured":"Jobe AH, Soll RF: Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol. 2004, 190: 878-881. 10.1016\/j.ajog.2004.01.044.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR105","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1053\/siny.2001.0065","volume":"6","author":"TM O'Shea","year":"2001","unstructured":"O'Shea TM, Doyle LW: Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. Semin Neonatol. 2001, 6: 293-307. 10.1053\/siny.2001.0065.","journal-title":"Semin Neonatol"},{"key":"206_CR106","doi-asserted-by":"publisher","first-page":"F154","DOI":"10.1136\/fn.83.2.F154","volume":"83","author":"A Whitelaw","year":"2000","unstructured":"Whitelaw A, Thoresen M: Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed. 2000, 83: F154-F157. 10.1136\/fn.83.2.F154.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"206_CR107","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJM199910143411604","volume":"341","author":"O Baud","year":"1999","unstructured":"Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, Huon C, Lepercq J, Dehan M, Lacaze-Masmonteil T: Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med. 1999, 341: 1190-1196. 10.1056\/NEJM199910143411604.","journal-title":"N Engl J Med"},{"key":"206_CR108","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0002-9378(99)70630-7","volume":"180","author":"MM Amorim","year":"1999","unstructured":"Amorim MM, Santos LC, Faundes A: Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol. 1999, 180: 1283-1288. 10.1016\/S0002-9378(99)70630-7.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR109","first-page":"CD004454","volume":"3","author":"D Roberts","year":"2006","unstructured":"Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006, 3: CD004454-","journal-title":"Cochrane Database Syst Rev"},{"key":"206_CR110","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/S0140-6736(06)68846-6","volume":"367","author":"CA Crowther","year":"2006","unstructured":"Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS: Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet. 2006, 367: 1913-1919. 10.1016\/S0140-6736(06)68846-6.","journal-title":"Lancet"},{"key":"206_CR111","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ajog.2006.03.087","volume":"195","author":"RJ Wapner","year":"2006","unstructured":"Wapner RJ, Sorokin Y, Thom EA, Johnson F, Dudley DJ, Spong CY, Peaceman AM, Leveno KJ, Harper M, Caritis SN, et al: Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol. 2006, 195: 633-642. 10.1016\/j.ajog.2006.03.087.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR112","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa071152","volume":"357","author":"CA Crowther","year":"2007","unstructured":"Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS: Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med. 2007, 357: 1179-1189. 10.1056\/NEJMoa071152.","journal-title":"N Engl J Med"},{"key":"206_CR113","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa071453","volume":"357","author":"RJ Wapner","year":"2007","unstructured":"Wapner RJ, Sorokin Y, Mele L, Johnson F, Dudley DJ, Spong CY, Peaceman AM, Leveno KJ, Malone F, Caritis SN, et al: Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007, 357: 1190-1198. 10.1056\/NEJMoa071453.","journal-title":"N Engl J Med"},{"key":"206_CR114","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0002-9378(99)70517-X","volume":"181","author":"BA Banks","year":"1999","unstructured":"Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA: Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol. 1999, 181: 709-717. 10.1016\/S0002-9378(99)70517-X.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR115","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.jp.7210604","volume":"22","author":"BA Banks","year":"2002","unstructured":"Banks BA, Macones G, Cnaan A, Merrill JD, Ballard PL, Ballard RA: Multiple courses of antenatal corticosteroids are associated with early severe lung disease in preterm neonates. J Perinatol. 2002, 22: 101-107. 10.1038\/sj.jp.7210604.","journal-title":"J Perinatol"},{"key":"206_CR116","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14767050500363519","volume":"19","author":"K Powell","year":"2006","unstructured":"Powell K, Kerkering KW, Barker G, Rozycki HJ: Dexamethasone dosing, mechanical ventilation and the risk of cerebral palsy. J Matern Fetal Neonatal Med. 2006, 19: 43-48. 10.1080\/14767050500363519.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"206_CR117","doi-asserted-by":"publisher","first-page":"e1621","DOI":"10.1542\/peds.2006-1522","volume":"118","author":"MJ Vincer","year":"2006","unstructured":"Vincer MJ, Allen AC, Joseph KS, Stinson DA, Scott H, Wood E: Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. Pediatrics. 2006, 118: e1621-e1626. 10.1542\/peds.2006-1522.","journal-title":"Pediatrics"},{"key":"206_CR118","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa032089","volume":"350","author":"TF Yeh","year":"2004","unstructured":"Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH: Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004, 350: 1304-1313. 10.1056\/NEJMoa032089.","journal-title":"N Engl J Med"},{"key":"206_CR119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9378(84)80100-3","volume":"150","author":"S Thiagarajah","year":"1984","unstructured":"Thiagarajah S, Bourgeois FJ, Harbert GM, Caudle MR: Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol. 1984, 150: 1-7.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR120","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1479-828X.1993.tb02375.x","volume":"33","author":"EF Magann","year":"1993","unstructured":"Magann EF, Graves GR, Roberts WE, Blake PG, Morrison JC, Martin JN: Corticosteroids for enhanced fetal lung maturation in patients with HELLP syndrome: impact on neonates. Aust N Z J Obstet Gynaecol. 1993, 33: 131-135. 10.1111\/j.1479-828X.1993.tb02375.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"206_CR121","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1055\/s-2000-13453","volume":"17","author":"EF Magann","year":"2000","unstructured":"Magann EF, Martin JN: Critical care of HELLP syndrome with corticosteroids. Am J Perinatol. 2000, 17: 417-422. 10.1055\/s-2000-13453.","journal-title":"Am J Perinatol"},{"key":"206_CR122","first-page":"CD002076","volume-title":"Cochrane Database Syst Rev","author":"P Matchaba","year":"2004","unstructured":"Matchaba P, Moodley J: Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev. 2004, CD002076-"},{"key":"206_CR123","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-9378(94)90054-X","volume":"171","author":"EF Magann","year":"1994","unstructured":"Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN: Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol. 1994, 171: 1148-1153.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR124","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0002-9378(94)90055-8","volume":"171","author":"EF Magann","year":"1994","unstructured":"Magann EF, Perry KG, Meydrech EF, Harris RL, Chauhan SP, Martin JN: Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol. 1994, 171: 1154-1158.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR125","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1067\/mob.2002.121074","volume":"186","author":"JM O'Brien","year":"2002","unstructured":"O'Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR: Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol. 2002, 186: 475-479. 10.1067\/mob.2002.121074.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR126","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/01.AOG.0000143262.85124.e8","volume":"104","author":"CH Rose","year":"2004","unstructured":"Rose CH, Thigpen BD, Bofill JA, Cushman J, May WL, Martin JN: Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome. Obstet Gynecol. 2004, 104: 1011-1014.","journal-title":"Obstet Gynecol"},{"key":"206_CR127","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0020-7292(97)00214-2","volume":"59","author":"GP Vigil-De","year":"1997","unstructured":"Vigil-De GP, Garcia-Caceres E: Dexamethasone in the post-partum treatment of HELLP syndrome. Int J Gynaecol Obstet. 1997, 59: 217-221. 10.1016\/S0020-7292(97)00214-2.","journal-title":"Int J Gynaecol Obstet"},{"key":"206_CR128","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0020-7292(98)00036-8","volume":"61","author":"OT Yalcin","year":"1998","unstructured":"Yalcin OT, Sener T, Hassa H, Ozalp S, Okur A: Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet. 1998, 61: 141-148. 10.1016\/S0020-7292(98)00036-8.","journal-title":"Int J Gynaecol Obstet"},{"key":"206_CR129","first-page":"64","volume":"50","author":"NS Qureshi","year":"2005","unstructured":"Qureshi NS, Tomlinson AJ: Prenatal corticosteroid therapy for elevated liver enzyme\/low platelet count syndrome: a case report. J Reprod Med. 2005, 50: 64-66.","journal-title":"J Reprod Med"},{"key":"206_CR130","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.ajog.2005.07.037","volume":"193","author":"JE Fonseca","year":"2005","unstructured":"Fonseca JE, Mendez F, Catano C, Arias F: Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005, 193: 1591-1598. 10.1016\/j.ajog.2005.07.037.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR131","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1053\/adnc.2002.36825","volume":"2","author":"P Lamer","year":"2002","unstructured":"Lamer P: Current controversies surrounding the use of repeated courses of antenatal steroids. Adv Neonatal Care. 2002, 2: 290-300. 10.1053\/adnc.2002.36825.","journal-title":"Adv Neonatal Care"},{"key":"206_CR132","first-page":"183","volume":"59","author":"AC Vidaeff","year":"2007","unstructured":"Vidaeff AC, Yeomans ER: Corticosteroids for the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): what evidence?. Minerva Ginecol. 2007, 59: 183-190.","journal-title":"Minerva Ginecol"},{"key":"206_CR133","doi-asserted-by":"crossref","unstructured":"Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000, 183: S1-S22. 10.1067\/mob.2000.107928.","DOI":"10.1067\/mob.2000.107928"},{"key":"206_CR134","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00044067-199711000-00003","volume":"8","author":"JH Poole","year":"1997","unstructured":"Poole JH: Aggressive management of HELLP syndrome and eclampsia. AACN Clin Issues. 1997, 8: 524-538.","journal-title":"AACN Clin Issues"},{"key":"206_CR135","first-page":"449","volume":"68","author":"S Mangione","year":"2002","unstructured":"Mangione S, Giarratano A: The role of antithrombin III in critical patients in obstetrics. Minerva Anestesiol. 2002, 68: 449-453.","journal-title":"Minerva Anestesiol"},{"key":"206_CR136","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-0037-1614071","volume":"84","author":"M Maki","year":"2000","unstructured":"Maki M, Kobayashi T, Terao T, Ikenoue T, Satoh K, Nakabayashi M, Sagara Y, Kajiwara Y, Urata M: Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group. Thromb Haemost. 2000, 84: 583-590.","journal-title":"Thromb Haemost"},{"key":"206_CR137","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0029-7844(98)00333-0","volume":"92","author":"MF Knapen","year":"1998","unstructured":"Knapen MF, Mulder TP, Van RI, Peters WH, Steegers EA: Low whole blood glutathione levels in pregnancies complicated by preeclampsia or the hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol. 1998, 92: 1012-1015. 10.1016\/S0029-7844(98)00333-0.","journal-title":"Obstet Gynecol"},{"key":"206_CR138","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0029-7844(96)00070-1","volume":"88","author":"C Lees","year":"1996","unstructured":"Lees C, Langford E, Brown AS, de BA, Pickles A, Martin JF, Campbell S: The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstet Gynecol. 1996, 88: 14-19. 10.1016\/0029-7844(96)00070-1.","journal-title":"Obstet Gynecol"},{"key":"206_CR139","first-page":"661","volume":"52","author":"FN Cho","year":"2007","unstructured":"Cho FN, Chen SN, Kan YY, Lee TC, Wang JS: Successful management of a pregnant woman with HELLP syndrome, pulmonary edema, postpartum hemorrhage and acute renal failure, using early hemodialysis, intravenous immunoglobulin and noninvasive monitoring: a case report. J Reprod Med. 2007, 52: 661-663.","journal-title":"J Reprod Med"},{"key":"206_CR140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.95.2.263","volume":"95","author":"KB Nelson","year":"1995","unstructured":"Nelson KB, Grether JK: Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?. Pediatrics. 1995, 95: 263-269.","journal-title":"Pediatrics"},{"key":"206_CR141","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1001\/jama.276.22.1805","volume":"276","author":"DE Schendel","year":"1996","unstructured":"Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P: Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA. 1996, 276: 1805-1810. 10.1001\/jama.276.22.1805.","journal-title":"JAMA"},{"key":"206_CR142","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00003081-199906000-00022","volume":"42","author":"RS Egerman","year":"1999","unstructured":"Egerman RS, Sibai BM: HELLP syndrome. Clin Obstet Gynecol. 1999, 42: 381-389. 10.1097\/00003081-199906000-00022.","journal-title":"Clin Obstet Gynecol"},{"key":"206_CR143","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/00006254-200209000-00023","volume":"57","author":"G Pridjian","year":"2002","unstructured":"Pridjian G, Puschett JB: Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet Gynecol Surv. 2002, 57: 598-618. 10.1097\/00006254-200209000-00023.","journal-title":"Obstet Gynecol Surv"},{"key":"206_CR144","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0020-7292(02)00394-6","volume":"80","author":"CM Isler","year":"2003","unstructured":"Isler CM, Magann EF, Rinehart BK, Terrone DA, Bass JD, Martin JN: Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome. Int J Gynaecol Obstet. 2003, 80: 291-297. 10.1016\/S0020-7292(02)00394-6.","journal-title":"Int J Gynaecol Obstet"},{"key":"206_CR145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00006250-199011000-00001","volume":"76","author":"JN Martin Jr","year":"1990","unstructured":"Martin JN, Blake PG, Lowry SL, Perry KG, Files JC, Morrison JC: Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery?. Obstet Gynecol. 1990, 76: 737-741.","journal-title":"Obstet Gynecol"},{"key":"206_CR146","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0002-9378(97)70005-X","volume":"177","author":"JN Martin Jr","year":"1997","unstructured":"Martin JN, Perry KG, Blake PG, May WA, Moore A, Robinette L: Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol. 1997, 177: 1011-1017. 10.1016\/S0002-9378(97)70005-X.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR147","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/01.AOG.0000154887.57440.d1","volume":"105","author":"PS Barrilleaux","year":"2005","unstructured":"Barrilleaux PS, Martin JN, Klauser CK, Bufkin L, May WL: Postpartum intravenous dexamethasone for severely preeclamptic patients without hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome: a randomized trial. Obstet Gynecol. 2005, 105: 843-848.","journal-title":"Obstet Gynecol"},{"key":"206_CR148","volume-title":"Am J Obstet Gynecol","author":"L Katz","year":"2008","unstructured":"Katz L, de Amorim MM, Figueiroa JN, JL ES: Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2008, [http:\/\/download.journals.elsevierhealth.com\/pdfs\/journals\/0002-9378\/PIIS0002937807020194.main-abr.pdf]"},{"key":"206_CR149","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9378(90)90835-U","volume":"162","author":"JN Martin Jr","year":"1990","unstructured":"Martin JN, Files JC, Blake PG, Norman PH, Martin RW, Hess LW, Morrison JC, Wiser WL: Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol. 1990, 162: 126-137.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR150","first-page":"99","volume":"17","author":"Z Bayraktaroglu","year":"2006","unstructured":"Bayraktaroglu Z, Demirci F, Balat O, Kutlar I, Okan V, Ugur G: Plasma exchange therapy in HELLP syndrome: A single-center experience. Turk J Gastroenterol. 2006, 17: 99-102.","journal-title":"Turk J Gastroenterol"},{"key":"206_CR151","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/107602960501100211","volume":"11","author":"B Eser","year":"2005","unstructured":"Eser B, Guven M, Unal A, Coskun R, Altuntas F, Sungur M, Serin IS, Sari I, Cetin M: The role of plasma exchange in HELLP syndrome. Clin Appl Thromb Hemost. 2005, 11: 211-217. 10.1177\/107602960501100211.","journal-title":"Clin Appl Thromb Hemost"},{"key":"206_CR152","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejogrb.2005.11.038","volume":"128","author":"GP Vigil-De","year":"2006","unstructured":"Vigil-De GP: Addition of platelet transfusions to corticosteroids does not increase the recovery of severe HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 2006, 128: 194-198. 10.1016\/j.ejogrb.2005.11.038.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"206_CR153","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bmj.38902.605347.7C","volume":"333","author":"KM Ho","year":"2006","unstructured":"Ho KM, Sheridan DJ: Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006, 333: 420-10.1136\/bmj.38902.605347.7C.","journal-title":"BMJ"},{"key":"206_CR154","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1159\/000095665","volume":"21","author":"P Hupuczi","year":"2006","unstructured":"Hupuczi P, Rigo B, Sziller I, Szabo G, Szigeti Z, Papp Z: Follow-up analysis of pregnancies complicated by HELLP syndrome. Fetal Diagn Ther. 2006, 21: 519-522. 10.1159\/000095665.","journal-title":"Fetal Diagn Ther"},{"key":"206_CR155","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0165-0378(03)00051-2","volume":"59","author":"G Dekker","year":"2003","unstructured":"Dekker G, Robillard PY: The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis. J Reprod Immunol. 2003, 59: 245-251. 10.1016\/S0165-0378(03)00051-2.","journal-title":"J Reprod Immunol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-9-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-9-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-9-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-9-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T01:29:51Z","timestamp":1684891791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-9-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,26]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-9-8","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,26]]},"assertion":[{"value":"2 September 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}